Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Jiansu Huachang Chemical Co., Ltd. Class A (002274.SZ)
Zhangjiagang, HEB, CN
Jiangsu Huachang Chemical Co., Ltd manufactures and sells agrochemicals, basic chemicals, fine chemicals, and biochemical products in China. It offers chemical products, such as industrial methanol, ammonium chloride, urea, sodium carbonate, anhydrous ammonia, nitric acid, and medicinal urea; and new material products, including n-butyraldehyde, isobutyraldehyde, n-butyl and isooctyl alcohol, propane, neopentylglycol, and polyester resin. It also offers potassium fulvic acid and marine algae loss control, flower, cash crop, urea ammonium nitrogen, bio-organic, stable, and specialized fertilizers. The company also produces and sells ecological fertilizers, and provision of new material technology development and waste management services. Jiangsu Huachang Chemical Co., Ltd was founded in 1970 and is headquartered in Zhangjiagang, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.63% | -7.49% | -17.75% | -14.98% | -10.47% | -1.59% | -22.88% | -26.46% | -31.95% | -8.10% | +8.38% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%-18.0% Q1'26: +3.2% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-138.2% Q1'26: +69.3% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%-11.2% Q1'26: +0.8% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%-4.4% Q1'26: +3.7% (vs Q1'25)
-
ROIC Chemicals: +3.4%-5.4% Q1'26: +3.9% (vs Q1'25)
-
Share dilution Chemicals: +0.0%0.0% Q1'26: +0.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×2.01× ★ Q1'26: 1.73× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
4.04B
est: 4.70B (-14.1%)
|
4.02B
est: 5.37B (-25.2%)
|
5.32B
est: 4.70B (+13.2%)
|
5.81B
est: 5.37B (+8.1%)
|
6.31B
est: 6.71B (-5.9%)
|
6.10B
est: 6.11B (-0.1%)
|
8.74B
est.
|
9.41B
est: 8.35B (+12.7%)
|
8.21B
est: 9.35B (-12.1%)
|
9.04B
est: 9.35B (-3.3%)
|
7.93B
est: 7.54B (+5.2%)
|
6.51B
est: 8.55B (-23.9%)
|
9.26B
9.26B – 9.26B
+8.3% YoY
|
| EBITDA |
457.08M
est: 843.71M (-45.8%)
|
461.40M
est: 964.96M (-52.2%)
|
474.33M
est: 843.71M (-43.8%)
|
576.91M
est: 964.96M (-40.2%)
|
750.37M
est: 1.21B (-37.7%)
|
711.25M
est: 1.10B (-35.1%)
|
1.57B
est.
|
2.62B
est: 1.50B (+74.7%)
|
1.43B
est: 1.68B (-14.9%)
|
1.57B
est: 1.68B (-6.5%)
|
1.16B
est: 1.21B (-3.5%)
|
177.99M
est: 1.37B (-87.0%)
|
1.48B
1.48B – 1.48B
+8.3% YoY
|
| EBIT |
199.27M
est: 576.57M (-65.4%)
|
147.85M
est: 659.42M (-77.6%)
|
160.04M
est: 576.57M (-72.2%)
|
259.00M
est: 659.42M (-60.7%)
|
357.49M
est: 823.54M (-56.6%)
|
313.90M
est: 749.40M (-58.1%)
|
1.07B
est.
|
2.21B
est: 1.03B (+115.6%)
|
980.58M
est: 1.15B (-14.6%)
|
1.15B
est: 1.15B (-0.2%)
|
685.28M
est: 789.01M (-13.1%)
|
-285.30M
est: 894.52M (-131.9%)
|
968.74M
968.74M – 968.74M
+8.3% YoY
|
| Net Income |
29.39M
est: 76.18M (-61.4%)
|
30.60M
est: 266.64M (-88.5%)
|
57.31M
est: 76.18M (-24.8%)
|
142.03M
est: 266.64M (-46.7%)
|
201.55M
est: 482.49M (-58.2%)
|
182.63M
est: 171.41M (+6.5%)
|
1.52B
est.
|
1.63B
est: 1.60B (+2.1%)
|
729.68M
est: 733.25M (-0.5%)
|
872.11M
est: 733.25M (+18.9%)
|
521.37M
est: 580.84M (-10.2%)
|
-204.34M
est: 695.10M (-129.4%)
|
790.32M
790.32M – 790.32M
+13.7% YoY
|
| SGA |
304.25M
est: 92.34M (+229.5%)
|
291.85M
est: 105.61M (+176.3%)
|
327.66M
est: 92.34M (+254.8%)
|
349.90M
est: 105.61M (+231.3%)
|
389.08M
est: 131.90M (+195.0%)
|
292.49M
est: 120.02M (+143.7%)
|
171.81M
est.
|
325.02M
est: 164.24M (+97.9%)
|
403.51M
est: 183.82M (+119.5%)
|
376.61M
est: 183.82M (+104.9%)
|
368.33M
est: 286.81M (+28.4%)
|
120.40M
est: 325.16M (-63.0%)
|
352.14M
352.14M – 352.14M
+8.3% YoY
|
| EPS |
0.04
est: 0.08 (-55.1%)
|
0.03
est: 0.28 (-88.5%)
|
0.06
est: 0.08 (-24.8%)
|
0.15
est: 0.28 (-46.4%)
|
0.21
est: 0.51 (-58.6%)
|
0.19
est: 0.18 (+5.6%)
|
1.60
est.
|
1.72
est: 1.68 (+2.4%)
|
0.77
est: 0.77 (+0.0%)
|
0.92
est: 0.77 (+19.5%)
|
0.55
est: 0.61 (-9.8%)
|
-0.21
est: 0.73 (-128.8%)
|
0.83
0.83 – 0.83
+13.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-28 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-27 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-26 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-25 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-22 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-21 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-20 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-19 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-18 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-15 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-14 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-13 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-12 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-11 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-08 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-07 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.00% | 34.1K | 0.65% |
| 2 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 110.9K | 0.39% |
| 3 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 73.4K | 0.29% |
| 4 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 49.4K | 0.28% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Han Qing Zhang | GM & Director | — | male |
| Hui Fen Zhao | Chief Financial Officer, Accounting Supervisor & Non-Independent Director | — | female |
| Long Lu | Secretary & Non-Independent Director | — | male |
| Xiao Wei He | Deputy GM & Non-Independent Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002274.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
